| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
3.64 -0.16 (-0.04%) |
01-18 16:00 |
|
Open: |
3.81 |
Pre close: |
3.8 |
Target:
|
4.87
|
|
High: |
3.83 |
Low: |
3.62 |
Resistance:
|
4.17
4.58
|
|
Volume: |
223,126 |
Market Cap: |
347M |
Support:
|
3.51
2.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.79
 |
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
4.01 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
4.39 |
Stochastic Oscillator |
%K(14,3):
|
14.27 |
|
MA(250): |
5.35 |
%D(3): |
14.31 |
|
Average Volume(K) |
3-Month: |
43782
|
52-Week |
High:
|
8.89 |
|
10-Days: |
23435 |
Low: |
2.73 |
|
RSI |
RSI(14):
|
40.71 |
Change(%): |
-12.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-36.1 |
Shares Out. (M) |
93.59 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-32.5 |
Shares Float (M) |
91.50 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
16.70 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.160 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.23 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.74 |
P/CF |
-23.94 |
|
|
|
|
|
|
